| Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder N Eissa, M Al-Houqani, A Sadeq, SK Ojha, A Sasse, B Sadek Frontiers in Neuroscience 12, 304, 2018 | 232 | 2018 |
| Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases B Sadek, A Saad, A Sadeq, F Jalal, H Stark Behavioural Brain Research 312, 415-430, 2016 | 173 | 2016 |
| Plant extracts and phytochemicals targeting α-synuclein aggregation in Parkinson's disease models H Javed, MF Nagoor Meeran, S Azimullah, A Adem, B Sadek, SK Ojha Frontiers in Pharmacology 9, 1555, 2019 | 94 | 2019 |
| Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283 A Bahi, JS Schwed, M Walter, H Stark, B Sadek Drug design, development and therapy, 627-637, 2014 | 81 | 2014 |
| Cherry-picked ligands at histamine receptor subtypes B Sadek, H Stark Neuropharmacology 106, 56-73, 2016 | 79 | 2016 |
| Menthol binding and inhibition of α7-nicotinic acetylcholine receptors A Ashoor, JC Nordman, D Veltri, KHS Yang, L Al Kury, Y Shuba, ... PloS one 8 (7), e67674, 2013 | 76 | 2013 |
| The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism N Eissa, P Jayaprakash, S Azimullah, SK Ojha, M Al-Houqani, FY Jalal, ... Scientific Reports 8 (1), 1-15, 2018 | 75 | 2018 |
| Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors M Mahgoub, SY Keun-Hang, V Sydorenko, A Ashoor, N Kabbani, ... European journal of pharmacology 720 (1-3), 310-319, 2013 | 75 | 2013 |
| Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD? N Eissa, A Sadeq, A Sasse, B Sadek Frontiers in pharmacology 11, 521283, 2020 | 71 | 2020 |
| Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats B Sadek, A Saad, D Subramanian, M Shafiullah, D Łażewska, ... Neuropharmacology 106, 46-55, 2016 | 67 | 2016 |
| Progress in the proxifan class: Heterocyclic congeners as novel potent and selective histamine H3-receptor antagonists S Graßmann, B Sadek, X Ligneau, S Elz, CR Ganellin, JM Arrang, ... European journal of pharmaceutical sciences 15 (4), 367-378, 2002 | 64 | 2002 |
| Plant-derived agents for counteracting cisplatin-induced nephrotoxicity S Ojha, B Venkataraman, A Kurdi, E Mahgoub, B Sadek, M Rajesh Oxidative medicine and cellular longevity 2016, 2016 | 60 | 2016 |
| Menthol inhibits 5-HT3 receptor–mediated currents A Ashoor, JC Nordman, D Veltri, KHS Yang, Y Shuba, L Al Kury, B Sadek, ... Journal of Pharmacology and Experimental Therapeutics 347 (2), 398-409, 2013 | 60 | 2013 |
| Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties B Sadek, JS Schwed, D Subramanian, L Weizel, M Walter, A Adem, ... European Journal of Medicinal Chemistry 77, 269-279, 2014 | 57 | 2014 |
| Novel Histamine H3-Receptor Antagonists with Carbonyl-Substituted 4-(3-(Phenoxy) propyl)-1 H-imidazole Structures like Ciproxifan and Related Compounds H Stark, B Sadek, M Krause, A Hüls, X Ligneau, CR Ganellin, JM Arrang, ... Journal of medicinal chemistry 43 (21), 3987-3994, 2000 | 54 | 2000 |
| Antimicrobial prospect of newly synthesized 1, 3-thiazole derivatives B Sadek, MM Al-Tabakha, KMS Fahelelbom Molecules 16 (11), 9386-9396, 2011 | 52 | 2011 |
| The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium … N Eissa, S Azimullah, P Jayaprakash, RL Jayaraj, D Reiner, SK Ojha, ... Chemico-biological Interactions 312, 108775, 2019 | 51 | 2019 |
| New histamine H3-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency A Sasse, B Sadek, X Ligneau, S Elz, HH Pertz, P Luger, CR Ganellin, ... Journal of medicinal chemistry 43 (17), 3335-3343, 2000 | 51 | 2000 |
| Small molecules from nature targeting G-protein coupled cannabinoid receptors: potential leads for drug discovery and development C Sharma, B Sadek, SN Goyal, S Sinha, MA Kamal, S Ojha Evidence-Based Complementary and Alternative Medicine 2015, 2015 | 48 | 2015 |
| Therapeutic potential of β-caryophyllene: a dietary cannabinoid in diabetes and associated complications HM Hashiesh, MFN Meeran, C Sharma, B Sadek, JA Kaabi, SK Ojha Nutrients 12 (10), 2963, 2020 | 45 | 2020 |
Holger StarkHeinrich Heine University Duesseldorf/GermanyVerified email at hhu.de
